Effect of iontophoresis on the in vitro trans-scleral transport of three single stranded oligonucleotides.

[1]  P. Santi,et al.  Effect Of Formulation Factors On The Trans-scleral Iontophoretic Transport Of A 40kDa Dextran In-vitro , 2011 .

[2]  P. Santi,et al.  Effect of formulation factors on the trans-scleral iontophoretic and post-iontophoretic transports of a 40 kDa dextran in vitro. , 2011, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[3]  Ying Chau,et al.  Ultrasound-enhanced intrascleral delivery of protein. , 2010, International journal of pharmaceutics.

[4]  R. Guy,et al.  Trans-scleral iontophoretic delivery of low molecular weight therapeutics. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[5]  P. Govoni,et al.  In‐vitro permeation of bevacizumab through human sclera: effect of iontophoresis application , 2010, The Journal of pharmacy and pharmacology.

[6]  S. Garg,et al.  Complications of intravitreal injections , 2010, Current opinion in ophthalmology.

[7]  S. K. Li,et al.  Iontophoretic transport of charged macromolecules across human sclera. , 2010, International journal of pharmaceutics.

[8]  D. Braun,et al.  Thermophoresis of single stranded DNA , 2010, Electrophoresis.

[9]  Mark R. Prausnitz,et al.  Suprachoroidal Drug Delivery to the Back of the Eye Using Hollow Microneedles , 2010, Pharmaceutical Research.

[10]  P. Santi,et al.  In vitro transscleral iontophoresis of high molecular weight neutral compounds. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[11]  E. Jeong,et al.  Transscleral iontophoretic and intravitreal delivery of a macromolecule: study of ocular distribution in vivo and postmortem with MRI. , 2009, Experimental eye research.

[12]  A. Auricchio,et al.  Ocular gene therapy: current progress and future prospects. , 2009, Trends in molecular medicine.

[13]  Mark R. Prausnitz,et al.  Intrascleral Drug Delivery to the Eye Using Hollow Microneedles , 2009, Pharmaceutical Research.

[14]  E. Souied,et al.  Non-invasive gene transfer by iontophoresis for therapy of an inherited retinal degeneration. , 2008, Experimental eye research.

[15]  M. Prausnitz,et al.  Coated microneedles for drug delivery to the eye. , 2007, Investigative ophthalmology & visual science.

[16]  E. Fattal,et al.  Ocular delivery of nucleic acids: antisense oligonucleotides, aptamers and siRNA. , 2006, Advanced drug delivery reviews.

[17]  D. Guyer,et al.  Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease , 2006, Nature Reviews Drug Discovery.

[18]  K. A. Jackson.  Mathematics of Diffusion , 2005 .

[19]  J. Nickerson,et al.  Scleral permeability of a small, single-stranded oligonucleotide. , 2004, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[20]  J. Parker,et al.  Intersitial exluded volumes: the effect of charge , 2003, The Journal of physiology.

[21]  H. Wiig,et al.  In vivo determination of steric and electrostatic exclusion of albumin in rat skin and skeletal muscle , 2003, The Journal of physiology.

[22]  Y. Courtois,et al.  Down-regulation of NOSII gene expression by iontophoresis of anti-sense oligonucleotide in endotoxin-induced uveitis. , 2002, Biochemical and biophysical research communications.

[23]  K. Kontturi,et al.  Conformation and ion-binding of oligonucleotides. , 2002, European Journal of Pharmaceutical Sciences.

[24]  Peter Gwynne,et al.  Drug Discovery: 5 , 2002 .

[25]  H. Shiota,et al.  Induction of gene into the rabbit eye by iontophoresis: preliminary report. , 2001, Japanese journal of ophthalmology.

[26]  E S Gragoudas,et al.  Diffusion of high molecular weight compounds through sclera. , 2000, Investigative ophthalmology & visual science.

[27]  G J van den Horn,et al.  Fomivirsen - a phosphorothioate oligonucleotide for the treatment of CMV retinitis. , 1999, Ocular immunology and inflammation.

[28]  P. Iversen,et al.  Effects of size and sequence on the iontophoretic delivery of oligonucleotides. , 1998, Journal of pharmaceutical sciences.

[29]  K. Oldenburg,et al.  Iontophoretic delivery of oligonucleotides across full thickness hairless mouse skin. , 1995, Journal of pharmaceutical sciences.

[30]  Jennifer I. Lim,et al.  Human scleral permeability. Effects of age, cryotherapy, transscleral diode laser, and surgical thinning. , 1995, Investigative ophthalmology & visual science.

[31]  M. Stephenson,et al.  Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[32]  M. Stephenson,et al.  Inhibition of Rous sarcoma viral RNA translation by a specific oligodeoxyribonucleotide. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[33]  D. Maurice,et al.  Diffusion across the sclera. , 1977, Experimental eye research.

[34]  Charles Tanford,et al.  Physical Chemistry of Macromolecules , 1961 .